Veradermics, INC Schedule 13D activist filings

Montanova Capital, LLC, Averill Master Fund, Ltd., Averill Madison Master Fund, Ltd., and Aaron Cowen have filed an amendment to their Schedule 13D, reporting changes in their beneficial ownership of Veradermics, Incorporated common stock.

SR One Capital Management and affiliated entities have filed an amendment to their Schedule 13D, reporting a sale of Veradermics, Inc. common stock and adjusting their beneficial ownership.

Suvretta Capital Management and its affiliates have acquired 300,000 pre-funded warrants in Veradermics, Inc., strengthening their 9.9% stake in the company.

Longitude Capital Partners and associated entities disclosed a 11.3% beneficial ownership stake in Veradermics, Incorporated.

Seven Fleet Master Fund LP has acquired 80,000 shares of Veradermics, Inc., representing a 0.2% ownership stake.

Longitude Capital and its affiliates, including board member Patrick G. Enright, reported a 12.5% beneficial ownership in Veradermics, Incorporated following recent IPO purchases and preferred stock conversions.

Suvretta Capital Management and its affiliated funds have disclosed an 11.9% beneficial ownership stake in Veradermics, Inc., following significant investments including preferred stock conversions, IPO participation, and open market purchases.

SR One Capital Management and affiliated funds have reported a 6.4% beneficial ownership in Veradermics, Inc. following the company's initial public offering and conversion of preferred stock.